{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:36:12Z","timestamp":1789619772888,"version":"build-2803163510"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["677772"],"award-info":[{"award-number":["677772"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["677772"],"award-info":[{"award-number":["677772"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["677772"],"award-info":[{"award-number":["677772"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["677772"],"award-info":[{"award-number":["677772"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.addr.2021.113901","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T22:09:53Z","timestamp":1627510193000},"page":"113901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics"],"prefix":"10.1016","volume":"176","author":[{"given":"Arbel","family":"Artzy-Schnirman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivan","family":"Arber Raviv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofri","family":"Doppelt Flikshtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeny","family":"Shklover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel","family":"Korin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"Sznitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.113901_b0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2014.10.011","article-title":"Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models","volume":"85","author":"Hittinger","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113901_b0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejpb.2017.02.019","article-title":"Cell and tissue-based in vitro models for improving the development of oral inhalation drug products","volume":"118","author":"Hittinger","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2021.113901_b0015","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201611-2248ST","article-title":"An official American thoracic society research statement: Current challenges facing research and therapeutic advances in airway remodeling","author":"Prakash","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1183\/09031936.00007915","article-title":"Barriers to new drug development in respiratory disease","volume":"45","author":"Barnes","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-pathol-012414-040418","article-title":"Engineered In Vitro Disease Models","volume":"10","author":"Benam","year":"2015","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"10","key":"10.1016\/j.addr.2021.113901_b0030","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.drudis.2018.05.017","article-title":"Current approaches to the discovery of novel inhaled medicines","volume":"23","author":"Strong","year":"2018","journal-title":"Drug Discov. Today."},{"issue":"19","key":"10.1016\/j.addr.2021.113901_b0035","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1039\/C9LC00492K","article-title":"Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective","volume":"19","author":"Ainslie","year":"2019","journal-title":"Lab Chip."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2020.11.009","article-title":"Organ-on-a-Chip: A New Paradigm for Drug Development","volume":"42","author":"Ma","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2021.113901_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/aogh.2411","article-title":"The global burden of pulmonary diseases: Most prevalent problems and opportunities for improvement","volume":"85","author":"Wisnivesky","year":"2019","journal-title":"Ann. Glob. Heal."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0050","article-title":"Chronic obstructive pulmonary disease","volume":"1","author":"Barnes","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10082","key":"10.1016\/j.addr.2021.113901_b0055","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","article-title":"Chronic obstructive pulmonary disease","volume":"389","author":"Rabe","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.113901_b0060","doi-asserted-by":"crossref","unstructured":"C.F. Vogelmeier, G.J. Criner, F.J. Martinez, A. Anzueto, P.J. Barnes, J. Bourbeau, B.R. Celli, R. Chen, M. Decramer, L.M. Fabbri, P. Frith, D.M.G. Halpin, M.V.L. Varela, M. Nishimura, N. Roche, R. Rodriguez-Roisin, D.D. Sin, D. Singh, R. Stockley, J. Vestbo, J.A. Wedzicha, A. Agust\u00ed, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report, Am. J. Respir. Crit. Care Med. 195 (2017) 557\u2013582. doi:10.1164\/rccm.201701-0218PP.","DOI":"10.1164\/rccm.201701-0218PP"},{"issue":"13","key":"10.1016\/j.addr.2021.113901_b0065","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1900475","article-title":"Update on the pathogenesis of chronic obstructive pulmonary disease","volume":"381","author":"Drazen","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.addr.2021.113901_b0070","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1164\/rccm.201501-0044ST","article-title":"An Official American Thoracic Society\/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease","volume":"191","author":"Celli","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2021.113901_b0075","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1183\/09031936.05.00139104","article-title":"COPD: current therapeutic interventions and future approaches","volume":"25","author":"Barnes","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2021.113901_b0080","doi-asserted-by":"crossref","unstructured":"H. Fehrenbach, Animal models of pulmonary emphysema: a stereologist\u2019s perspective, 15 (2006) 136\u2013147. doi:10.1183\/09059180.00010104.","DOI":"10.1183\/09059180.00010104"},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0085","doi-asserted-by":"crossref","first-page":"1901417","DOI":"10.1183\/13993003.01417-2019","article-title":"H2020 funding for respiratory research: Scaling up for the prevention and treatment of lung diseases","volume":"54","author":"Vardavas","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-physiol-021014-071937","article-title":"Dynamics of lung defense in pneumonia: Resistance, resilience, and remodeling","volume":"77","author":"Quinton","year":"2015","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"10.1016\/j.addr.2021.113901_b0095","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1513\/AnnalsATS.201603-194FR","article-title":"Microbial biofilms in pulmonary and critical care diseases","volume":"13","author":"Boisvert","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.addr.2021.113901_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apm.12099","article-title":"The role of bacterial biofilms in chronic infections","volume":"121","author":"Bjarnsholt","year":"2013","journal-title":"APMIS."},{"key":"10.1016\/j.addr.2021.113901_b0105","doi-asserted-by":"crossref","unstructured":"T. Qvist, S. Eickhardt, K.N. Kragh, C.B. Andersen, M. Iversen, N. H\u00f8iby, T. Bjarnsholt, Chronic pulmonary disease with <em>Mycobacterium abscessus<\/em> complex is a biofilm infection, Eur. Respir. J. 46 (2015) 1823 LP \u2013 1826. doi:10.1183\/13993003.01102-2015.","DOI":"10.1183\/13993003.01102-2015"},{"key":"10.1016\/j.addr.2021.113901_b0110","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"issue":"10063","key":"10.1016\/j.addr.2021.113901_b0115","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2020.10.016","article-title":"Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies","volume":"26","author":"Montefusco-Pereira","year":"2021","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.addr.2021.113901_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"10.1016\/j.addr.2021.113901_b0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(20)30304-0","article-title":"COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?","volume":"8","author":"Fan","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.addr.2021.113901_b0135","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","article-title":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study","volume":"8","author":"Grasselli","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.addr.2021.113901_b0140","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/17476348.2020.1804365","article-title":"Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis","volume":"14","author":"Hasan","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"issue":"7825","key":"10.1016\/j.addr.2021.113901_b0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/d41586-020-02598-6","article-title":"The lasting misery of coronavirus long-haulers","volume":"585","author":"Marshall","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.113901_b0150","article-title":"Long term respiratory complications of covid-19","volume":"370","author":"Fraser","year":"2020","journal-title":"BMJ"},{"issue":"10270","key":"10.1016\/j.addr.2021.113901_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(21)00039-8","article-title":"Long-term follow-up of recovered patients with COVID-19","volume":"397","author":"Cortinovis","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.113901_b0160","doi-asserted-by":"crossref","unstructured":"H.B. Van Der Worp, D.W. Howells, E.S. Sena, M.J. Porritt, S. Rewell, O. Collins, M.R. Macleod, Can Animal Models of Disease Reliably Inform Human Studies\u00a0? 7 (2010). doi:10.1371\/journal.","DOI":"10.1371\/journal.pmed.1000245"},{"issue":"15-16","key":"10.1016\/j.addr.2021.113901_b0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.drudis.2011.05.014","article-title":"Animal models of asthma: Value, limitations and opportunities for alternative approaches","volume":"16","author":"Holmes","year":"2011","journal-title":"Drug Discov. Today."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0170","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.addr.2021.113901_b0175","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pathol.4.110807.092145","article-title":"The Pathology of Chronic Obstructive Pulmonary Disease","volume":"4","author":"Hogg","year":"2009","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"0","key":"10.1016\/j.addr.2021.113901_b0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14356\/kona.2019008","article-title":"Challenges Associated with the Pulmonary Delivery of Therapeutic Dry Powders for Preclinical Testing","volume":"36","author":"Price","year":"2019","journal-title":"KONA Powder Part. J. advpub"},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4155\/tde-2000-0000","article-title":"Inhaled formulation and device selection: bridging the gap between preclinical species and first-in-human studies","volume":"9","author":"Wylie","year":"2018","journal-title":"Ther. Deliv."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-016-2566-8","article-title":"Airway remodeling in asthma: what really matters","volume":"367","author":"Fehrenbach","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0200","first-page":"246","article-title":"In Vitro Models to Study Human Lung Development","volume":"32","author":"Miller","year":"2017","journal-title":"Disease and Homeostasis"},{"key":"10.1016\/j.addr.2021.113901_b0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cobme.2019.11.003","article-title":"Multiscale in silico lung modeling strategies for aerosol inhalation therapy and drug delivery","volume":"11","author":"Koullapis","year":"2019","journal-title":"Curr. Opin. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0210","doi-asserted-by":"crossref","first-page":"042209","DOI":"10.1063\/1.5023034","article-title":"Biomimetics of the pulmonary environment in vitro: A microfluidics perspective","volume":"12","author":"Tenenbaum-Katan","year":"2018","journal-title":"Biomicrofluidics."},{"issue":"9","key":"10.1016\/j.addr.2021.113901_b0215","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1535370214536679","article-title":"Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use","volume":"239","author":"Nichols","year":"2014","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.addr.2021.113901_b0220","doi-asserted-by":"crossref","unstructured":"J.P. Guyette, S.E. Gilpin, J.M. Charest, L.F. Tapias, X. Ren, H.C. Ott, Perfusion decellularization of whole organs, 9 (2014) 1451\u20131468. doi:10.1038\/nprot.2014.097.","DOI":"10.1038\/nprot.2014.097"},{"issue":"17-18","key":"10.1016\/j.addr.2021.113901_b0225","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1089\/ten.tea.2012.0250","article-title":"Production and Assessment of Decellularized Pig and Human Lung Scaffolds","volume":"19","author":"Nichols","year":"2013","journal-title":"Tissue Eng."},{"key":"10.1016\/j.addr.2021.113901_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/16000617.0021-2018","article-title":"Acellular human lung scaffolds to model lung disease and tissue regeneration","volume":"27","author":"Gilpin","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0240","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00441-016-2541-4","article-title":"Lung morphometry: the link between structure and function","volume":"367","author":"Weibel","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.addr.2021.113901_b0245","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/j.2040-4603.2016.tb00698.x","article-title":"Lung Structure and the Intrinsic Challenges of Gas Exchange","volume":"6","author":"Hsia","year":"2016","journal-title":"Compr. Physiol."},{"issue":"1-2","key":"10.1016\/j.addr.2021.113901_b0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resp.2005.03.005","article-title":"Design of peripheral airways for efficient gas exchange","volume":"148","author":"Weibel","year":"2005","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.addr.2021.113901_b0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2014.05.014","article-title":"Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery","volume":"75","author":"de Souza Carvalho","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0260","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1039\/c2ib00176d","article-title":"Organs-on-chips: breaking the in vitro impasse","volume":"4","author":"van der Meer","year":"2012","journal-title":"Integr. Biol."},{"issue":"9","key":"10.1016\/j.addr.2021.113901_b0265","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00204-015-1518-5","article-title":"Progress and future of in vitro models to study translocation of nanoparticles","volume":"89","author":"Braakhuis","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00408-016-9875-2","article-title":"Cells and Culture Systems Used to Model the Small Airway Epithelium","volume":"194","author":"Bhowmick","year":"2016","journal-title":"Lung"},{"issue":"39","key":"10.1016\/j.addr.2021.113901_b0275","doi-asserted-by":"crossref","first-page":"1903114","DOI":"10.1002\/adfm.201903114","article-title":"Evolution of Bioengineered Lung Models: Recent Advances and Challenges in Tissue Mimicry for Studying the Role of Mechanical Forces in Cell Biology","volume":"29","author":"Doryab","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"23","key":"10.1016\/j.addr.2021.113901_b0280","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1111\/febs.14582","article-title":"A guide to polarized airway epithelial models for studies of host \u2013 pathogen interactions","volume":"285","author":"Hasan","year":"2018","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0285","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejps.2013.06.004","article-title":"In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals","volume":"49","author":"Nahar","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.pupt.2010.12.002","article-title":"What can in vitro models of COPD tell us?","volume":"24","author":"Krimmer","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2021.113901_b0295","doi-asserted-by":"crossref","unstructured":"G. Lacroix, W. Koch, S.T. Larsen, T. Loret, F. Zanetti, S. Constant, S. Chortarea, B. Rothen-rutishauser, P.S. Hiemstra, E. Frejafon, P. Hubert, L. Gribaldo, P. Kearns, J. Aublant, Air \u2013 Liquid Interface In Vitro Models for Respiratory Toxicology Research\u00a0:, 4 (2018) 91\u2013106. doi:10.1089\/aivt.2017.0034.","DOI":"10.1089\/aivt.2017.0034"},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/aivt.2018.0002","article-title":"Through the Looking Glass. In Vitro Models for Inhalation Toxicology and Interindividual Variability in the Airway","volume":"4","author":"Faber","year":"2018","journal-title":"Appl. Vitr. Toxicol."},{"key":"10.1016\/j.addr.2021.113901_b0305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2017.12.013","article-title":"Engineered cell and tissue models of pulmonary fibrosis","volume":"129","author":"Sundarakrishnan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113901_b0310","doi-asserted-by":"crossref","unstructured":"J.L. Sporty, L. Hor\u00e1lkov\u00e1, C. Ehrhardt, Expert Opinion on Drug Metabolism & Toxicology In vitro cell culture models for the assessment of pulmonary drug disposition In vitro cell culture models for the assessment of pulmonary 5255 (2008). doi:10.1517\/17425255.4.4.333.","DOI":"10.1517\/17425255.4.4.333"},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2005.02.010","article-title":"Human respiratory epithelial cell culture for drug delivery applications","volume":"60","author":"Forbes","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0320","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2010.10.014","article-title":"An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier","volume":"77","author":"Lehmann","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1165\/rcmb.2004-0187OC","article-title":"A Three-Dimensional Cellular Model of the Human Respiratory Tract to Study the Interaction with Particles","volume":"32","author":"Rothen-Rutishauser","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.addr.2021.113901_b0330","first-page":"251","article-title":"Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier","volume":"33","author":"Kuehn","year":"2016","journal-title":"ALTEX."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0335","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1164\/rccm.201409-1663OE","article-title":"On the tricks alveolar epithelial cells play to make a good lung","volume":"191","author":"Weibel","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2021.113901_b0340","series-title":"The Pathway for Oxygen: Structure and Function in the Mammalian Respiratory System","author":"Weibel","year":"1984"},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0345","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymgme.2009.01.015","article-title":"An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease","volume":"97","author":"Nkadi","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0350","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-pathol-012513-104644","article-title":"Diseases of Pulmonary Surfactant Homeostasis","volume":"10","author":"Whitsett","year":"2015","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0355","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1513\/pats.200708-126ET","article-title":"Pathogenesis of emphysema: From the bench to the bedside","volume":"5","author":"Sharafkhaneh","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0360","doi-asserted-by":"crossref","first-page":"C1179","DOI":"10.1152\/ajpcell.00355.2004","article-title":"Stretch increases alveolar epithelial permeability to uncharged micromolecules","volume":"290","author":"Cavanaugh","year":"2006","journal-title":"Am. J. Physiol. - Cell Physiol."},{"issue":"9795","key":"10.1016\/j.addr.2021.113901_b0365","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","article-title":"New insights into the immunology of chronic obstructive pulmonary disease","volume":"378","author":"Brusselle","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0370","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1183\/09031936.00036709","article-title":"Defective macrophage phagocytosis of bacteria in COPD","volume":"35","author":"Taylor","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0375","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.11-2348","article-title":"Defective phagocytosis in airways disease","volume":"141","author":"Donnelly","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46045-7","article-title":"Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress","volume":"9","author":"Aridgides","year":"2019","journal-title":"Sci. Rep."},{"issue":"9-10","key":"10.1016\/j.addr.2021.113901_b0385","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.addr.2006.07.012","article-title":"In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery","volume":"58","author":"Sakagami","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113901_b0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2020.07.025","article-title":"In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs","volume":"161\u2013162","author":"Sakagami","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113901_b0395","doi-asserted-by":"crossref","unstructured":"C.A. Fernandes, R. Vanbever, C.A. Fernandes, R. Vanbever, Preclinical models for pulmonary drug delivery Preclinical models for pulmonary drug delivery 5247 (2009). doi:10.1517\/17425240903241788.","DOI":"10.1517\/17425240903241788"},{"issue":"S2","key":"10.1016\/j.addr.2021.113901_b0400","first-page":"S-71","article-title":"The Particle has Landed\u2014Characterizing the Fate of Inhaled Pharmaceuticals, J. Aerosol Med. Pulm","volume":"23","author":"Patton","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2021.113901_b0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2019.04.037","article-title":"Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air-blood barrier","volume":"91","author":"Costa","year":"2019","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0410","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2017.09.027","article-title":"A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery","volume":"532","author":"R\u00f6hm","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.113901_b0415","doi-asserted-by":"crossref","first-page":"14359","DOI":"10.1038\/s41598-018-32523-x","article-title":"Medium throughput breathing human primary cell alveolus-on-chip model","volume":"8","author":"Stucki","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0420","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/jam.2006.19.392","article-title":"An optimized in vitro model of the respiratory tract wall to study particle cell interactions","volume":"19","author":"Blank","year":"2006","journal-title":"J. Aerosol Med. Off. J. Int. Soc. Aerosols Med."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0425","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1165\/rcmb.2013-0479OC","article-title":"Efficient bioactive delivery of aerosolized drugs to human pulmonary epithelial cells cultured in air-liquid interface conditions","volume":"51","author":"Lenz","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0430","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/026119291003800408","article-title":"The Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) in vitro system: Design and experimental protocol","volume":"38","author":"Hein","year":"2010","journal-title":"ATLA Altern. to Lab. Anim."},{"key":"10.1016\/j.addr.2021.113901_b0435","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3762\/bjnano.5.149","article-title":"Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches","volume":"5","author":"Herzog","year":"2014","journal-title":"Beilstein J. Nanotechnol."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0440","doi-asserted-by":"crossref","first-page":"L817","DOI":"10.1152\/ajplung.00442.2007","article-title":"Interactions of nanoparticles with pulmonary structures and cellular responses","volume":"294","author":"M\u00fchlfeld","year":"2008","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.addr.2021.113901_b0445","doi-asserted-by":"crossref","unstructured":"D. Huh, B.D. Matthews, A. Mammoto, M. Montoya-Zavala, H.Y. Hsin, D.E. Ingber, Reconstituting Organ-Level Lung Functions on a Chip, Science (80-.). 328 (2010) 1662\u20131668. doi:10.1126\/science.1188302.","DOI":"10.1126\/science.1188302"},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0450","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/17435390.2014.940402","article-title":"Microfluidic platforms for advanced risk assessments of nanomaterials","volume":"9","author":"Mahto","year":"2015","journal-title":"Nanotoxicology."},{"issue":"7","key":"10.1016\/j.addr.2021.113901_b0455","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.201709-1795PP","article-title":"Breaking the in vitro barrier in respiratory medicine: Engineered microphysiological systems for chronic obstructive pulmonary disease and beyond","volume":"197","author":"Benam","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.addr.2021.113901_b0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2019.09.006","article-title":"Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline","volume":"144","author":"Artzy-Schnirman","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0465","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrd4539","article-title":"Organs-on-chips at the frontiers of drug discovery","volume":"14","author":"Esch","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.addr.2021.113901_b0470","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2021.113901_b0475","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2017.08.003","article-title":"Current developments and applications of microfluidic technology toward clinical translation of nanomedicines","volume":"128","author":"Liu","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.addr.2021.113901_b0480","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1002\/jcp.27729","article-title":"Organ-on-chip models: Implications in drug discovery and clinical applications","volume":"234","author":"Mittal","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0485","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.dmpk.2017.11.003","article-title":"Organ\/body-on-a-chip based on microfluidic technology for drug discovery","volume":"33","author":"Kimura","year":"2018","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0490","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.drudis.2019.03.011","article-title":"Organ-on-a-chip technology: turning its potential for clinical benefit into reality","volume":"24","author":"Haddrick","year":"2019","journal-title":"Drug Discov. Today."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0495","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/07388551.2019.1710458","article-title":"Lung-on-a-chip: the future of respiratory disease models and pharmacological studies","volume":"40","author":"Shrestha","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"issue":"8","key":"10.1016\/j.addr.2021.113901_b0500","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41578-018-0034-7","article-title":"Advances in organ-on-a-chip engineering","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Rev. Mater."},{"issue":"14","key":"10.1016\/j.addr.2021.113901_b0505","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1039\/C6LC01554A","article-title":"Organ-on-a-chip devices advance to market","volume":"17","author":"Zhang","year":"2017","journal-title":"Lab Chip."},{"issue":"22","key":"10.1016\/j.addr.2021.113901_b0510","first-page":"2002030","article-title":"Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies ? 3","volume":"7","author":"Ingber","year":"2020","journal-title":"Are there Viable In Vitro Alternatives to Animal"},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0515","doi-asserted-by":"crossref","first-page":"1702133","DOI":"10.1183\/13993003.02133-2017","article-title":"Optimising experimental research in respiratory diseases: An ERS statement","volume":"51","author":"Bonniaud","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0520","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ar.1092200410","article-title":"Morphometry of the human pulmonary acinus","volume":"220","author":"Haefeli-Bleuer","year":"1988","journal-title":"Anat. Rec."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0525","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.00003308","article-title":"How to make an alveolus","volume":"31","author":"Weibel","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2021.113901_b0530","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tiv.2017.11.005","article-title":"Human lung epithelial cell cultures for analysis of inhaled toxicants: Lessons learned and future directions","volume":"47","author":"Hiemstra","year":"2018","journal-title":"Toxicol. Vitr."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0535","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41596-018-0104-8","article-title":"Generation of lung organoids from human pluripotent stem cells in vitro","volume":"14","author":"Miller","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2021.113901_b0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2014.02.008","article-title":"Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments","volume":"69\u201370","author":"Astashkina","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113901_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28715-0","article-title":"Engineering biofunctional in vitro vessel models using a multilayer bioprinting technique","volume":"8","author":"Sch\u00f6neberg","year":"2018","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.addr.2021.113901_b0550","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1073\/pnas.1221526110","article-title":"Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro","volume":"110","author":"Nguyen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"38","key":"10.1016\/j.addr.2021.113901_b0555","doi-asserted-by":"crossref","first-page":"eabb3629","DOI":"10.1126\/sciadv.abb3629","article-title":"3D curvature-instructed endothelial flow response and tissue vascularization","volume":"6","author":"Mandrycky","year":"2020","journal-title":"Sci. Adv."},{"issue":"24","key":"10.1016\/j.addr.2021.113901_b0560","doi-asserted-by":"crossref","first-page":"9342","DOI":"10.1073\/pnas.1201240109","article-title":"In vitro microvessels for the study of angiogenesis and thrombosis","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2021.113901_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/mi9100493","article-title":"Microfluidic-based 3D engineered microvascular networks and their applications in vascularized microtumor models","volume":"9","author":"Wang","year":"2018","journal-title":"Micromachines."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0570","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jbiomech.2012.10.028","article-title":"Respiratory microflows in the pulmonary acinus","volume":"46","author":"Sznitman","year":"2013","journal-title":"J. Biomech."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0575","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1152\/jappl.1988.64.5.2132","article-title":"A model of the lung structure and its validation","volume":"64","author":"Fung","year":"1988","journal-title":"J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0580","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0585","doi-asserted-by":"crossref","first-page":"014120","DOI":"10.1063\/1.4908269","article-title":"Biomimetics of fetal alveolar flow phenomena using microfluidics","volume":"9","author":"Tenenbaum-Katan","year":"2015","journal-title":"Biomicrofluidics."},{"issue":"7","key":"10.1016\/j.addr.2021.113901_b0590","doi-asserted-by":"crossref","first-page":"L672","DOI":"10.1152\/ajplung.00106.2013","article-title":"Microfluidic shear stress-regulated surfactant secretion in alveolar epithelial type II cells in vitro","volume":"306","author":"Mahto","year":"2014","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"issue":"9","key":"10.1016\/j.addr.2021.113901_b0595","doi-asserted-by":"crossref","first-page":"1900026","DOI":"10.1002\/adbi.201900026","article-title":"Capturing the Onset of Bacterial Pulmonary Infection in Acini-On-Chips","volume":"3","author":"Artzy\u2010Schnirman","year":"2019","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.addr.2021.113901_b0600","doi-asserted-by":"crossref","DOI":"10.1115\/1.4040272","article-title":"Organ-on-Chip Devices Toward Applications in Drug Development and Screening","volume":"12","author":"Uhl","year":"2018","journal-title":"J. Med. Device."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0605","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10439-016-1607-5","article-title":"State-of-the-Art Review of 3D Bioprinting for Cardiovascular Tissue Engineering","volume":"45","author":"Duan","year":"2017","journal-title":"Ann. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0610","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/ten.teb.2015.0464","article-title":"A Review of Three-Dimensional Printing in Tissue Engineering","volume":"22","author":"Sears","year":"2016","journal-title":"Tissue Eng. - Part B Rev."},{"key":"10.1016\/j.addr.2021.113901_b0615","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1038\/srep07974","article-title":"Engineering an in vitro air-blood barrier by 3D bioprinting","volume":"5","author":"Horv\u00e1th","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.addr.2021.113901_b0620","article-title":"Multiscale Co-reconstruction of Lung Architectures and Inhalable Materials Spatial","volume":"8","author":"Sun","year":"2021","journal-title":"Distribution"},{"key":"10.1016\/j.addr.2021.113901_b0625","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","author":"Frantz","year":"2010","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.addr.2021.113901_b0630","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1165\/rcmb.2015-0166PS","article-title":"Matrix remodeling in pulmonary fibrosis and emphysema","volume":"54","author":"Kulkarni","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0635","doi-asserted-by":"crossref","first-page":"1601805","DOI":"10.1183\/13993003.01805-2016","article-title":"The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease","volume":"50","author":"Burgstaller","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0640","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bit.22361","article-title":"Hydrogels as extracellular matrix mimics for 3D cell culture","volume":"103","author":"Tibbitt","year":"2009","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0645","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ydbio.2009.10.026","article-title":"The extracellular matrix in development and morphogenesis: A dynamic view","volume":"341","author":"Rozario","year":"2010","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0650","doi-asserted-by":"crossref","first-page":"042207","DOI":"10.1063\/1.5024895","article-title":"Incorporating mechanical strain in organs-on-a-chip: Lung and skin","volume":"12","author":"Guenat","year":"2018","journal-title":"Biomicrofluidics."},{"key":"10.1016\/j.addr.2021.113901_b0655","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s42003-021-01695-0","article-title":"Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane","volume":"4","author":"Zamprogno","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.addr.2021.113901_b0660","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1152\/jappl.2001.91.2.589","article-title":"Mechanical stretch promotes alveolar epithelial type II cell differentiation","volume":"91","author":"Sanchez-Esteban","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2021.113901_b0665","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3389\/fbioe.2020.602646","article-title":"Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models","volume":"8","author":"Thompson","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0670","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1039\/C4LC01252F","article-title":"A lung-on-a-chip array with an integrated bio-inspired respiration mechanism","volume":"15","author":"Stucki","year":"2015","journal-title":"Lab Chip."},{"key":"10.1016\/j.addr.2021.113901_b0675","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.616830","article-title":"A Bioinspired In Vitro Lung Model to Study Particokinetics of Nano-\/Microparticles under Cyclic Stretch and Air-Liquid Interface Conditions","volume":"9","author":"Doryab","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0680","doi-asserted-by":"crossref","first-page":"L1025","DOI":"10.1152\/ajplung.00077.2004","article-title":"Viscoelasticity of human alveolar epithelial cells subjected to stretch","volume":"287","author":"Trepat","year":"2004","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.addr.2021.113901_b0685","doi-asserted-by":"crossref","unstructured":"D. Huh, D.C. Leslie, B.D. Matthews, J.P. Fraser, S. Jurek, G.A. Hamilton, K.S. Thorneloe, M.A. McAlexander, D.E. Ingber, A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice, Sci. Transl. Med. (2012). doi:10.1126\/scitranslmed.3004249.","DOI":"10.1126\/scitranslmed.3004249"},{"key":"10.1016\/j.addr.2021.113901_b0690","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2019.00003","article-title":"Impaired wound healing of alveolar lung epithelial cells in a breathing lung-on-a-chip","volume":"7","author":"Felder","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2021.113901_b0695","doi-asserted-by":"crossref","first-page":"120436","DOI":"10.1016\/j.biomaterials.2020.120436","article-title":"3D alveolar in vitro model based on epithelialized biomimetically curved culture membranes","volume":"266","author":"Baptista","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113901_b0700","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2017.09.033","article-title":"One (sub-)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures","volume":"113","author":"Hofemeier","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"14","key":"10.1016\/j.addr.2021.113901_b0705","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/j.jbiomech.2016.08.025","article-title":"The role of anisotropic expansion for pulmonary acinar aerosol deposition","volume":"49","author":"Hofemeier","year":"2016","journal-title":"J. Biomech."},{"key":"10.1016\/j.addr.2021.113901_b0710","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejps.2017.09.016","article-title":"An efficient computational fluid-particle dynamics method to predict deposition in a simplified approximation of the deep lung","volume":"113","author":"Koullapis","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"16","key":"10.1016\/j.addr.2021.113901_b0715","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jbiomech.2013.08.020","article-title":"Acinus-on-a-chip: A microfluidic platform for pulmonary acinar flows","volume":"46","author":"Fishler","year":"2013","journal-title":"J. Biomech."},{"issue":"3","key":"10.1016\/j.addr.2021.113901_b0720","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jamp.2011.0916","article-title":"Aerosol deposition in health and disease","volume":"25","author":"Darquenne","year":"2012","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2021.113901_b0725","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1152\/japplphysiol.01117.2014","article-title":"Revisiting pulmonary acinar particle transport: convection, sedimentation, diffusion and their interplay","volume":"118","author":"Hofemeier","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2021.113901_b0730","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jbiomech.2016.11.043","article-title":"Streamline crossing: An essential mechanism for aerosol dispersion in the pulmonary acinus","volume":"50","author":"Fishler","year":"2017","journal-title":"J. Biomech."},{"key":"10.1016\/j.addr.2021.113901_b0735","doi-asserted-by":"crossref","first-page":"105003","DOI":"10.1016\/j.ejps.2019.105003","article-title":"Targeting inhaled fibers to the pulmonary acinus: Opportunities for augmented delivery from in silico simulations","volume":"137","author":"Shachar-Berman","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"49","key":"10.1016\/j.addr.2021.113901_b0740","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201904112","article-title":"Multimodal Precision Imaging of Pulmonary Nanoparticle Delivery in Mice: Dynamics of Application, Spatial Distribution, and Dosimetry","volume":"15","author":"Yang","year":"2019","journal-title":"Small."},{"key":"10.1016\/j.addr.2021.113901_b0745","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1038\/srep14071","article-title":"Particle dynamics and deposition in true-scale pulmonary acinar models","volume":"5","author":"Fishler","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0750","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10494-018-9927-1","article-title":"Targeted Drug Delivery to Upper Airways Using a Pulsed Aerosol Bolus and Inhaled Volume Tracking Method, Flow","volume":"102","author":"Ostrovski","year":"2019","journal-title":"Turbul. Combust."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0755","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.addr.2011.05.009","article-title":"In silico models of aerosol delivery to the respiratory tract - development and applications","volume":"64","author":"Longest","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0760","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jamp.2012.0997","article-title":"Targeting aerosol deposition to and within the lung airways using excipient enhanced growth","volume":"26","author":"Tian","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2021.113901_b0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0207711","article-title":"Targeting inhaled aerosol delivery to upper airways in children: Insight from computational fluid dynamics (CFD)","volume":"13","author":"Das","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.113901_b0770","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fbioe.2020.00091","article-title":"In situ-like aerosol inhalation exposure for cytotoxicity assessment using airway-on-chips platforms","volume":"8","author":"Elias-Kirma","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2021.113901_b0775","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2013.11.007","article-title":"Delivery of inhalation drugs to children for asthma and other respiratory diseases","volume":"73","author":"Kwok","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0780","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jamp.2016.1297","article-title":"The History of Therapeutic Aerosols: A Chronological Review","volume":"30","author":"Stein","year":"2017","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"9770","key":"10.1016\/j.addr.2021.113901_b0785","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.113901_b0790","doi-asserted-by":"crossref","unstructured":"N.R. Labiris, M.B. Dolovich, Pulmonary drug delivery . Part II\u00a0: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications, (2003). doi:10.1046\/j.1365-2125.2003.01893.x.","DOI":"10.1046\/j.1365-2125.2003.01893.x"},{"key":"10.1016\/j.addr.2021.113901_b0795","first-page":"1161","article-title":"The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination","volume":"50","author":"Laube","year":"2005","journal-title":"Respir. Care."},{"key":"10.1016\/j.addr.2021.113901_b0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2213-0802-2-3","article-title":"The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update","volume":"2","author":"Laube","year":"2014","journal-title":"Transl. Respir. Med."},{"issue":"6","key":"10.1016\/j.addr.2021.113901_b0805","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4187\/respcare.03554","article-title":"Aerosolized Medications for Gene and Peptide Therapy","volume":"60","author":"Laube","year":"2015","journal-title":"Respir. Care."},{"issue":"9-10","key":"10.1016\/j.addr.2021.113901_b0810","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.addr.2006.07.009","article-title":"Clinical perspectives on pulmonary systemic and macromolecular delivery","volume":"58","author":"Scheuch","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113901_b0815","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1465-9921-15-60","article-title":"Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization","volume":"15","author":"Rajapaksa","year":"2014","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0820","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.addr.2021.113901_b0825","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/17425247.4.6.575","article-title":"Pulmonary delivery of nucleic acids","volume":"4","author":"Birchall","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2021.113901_b0830","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I : Physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.addr.2021.113901_b0835","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/jac\/dkv192","article-title":"Pulmonary drug delivery: A review on nanocarriers for antibacterial chemotherapy","volume":"70","author":"Moreno-Sastre","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2021.113901_b0840","first-page":"367","article-title":"The inhalation of drugs: advantages and problems","volume":"50","author":"Rau","year":"2005","journal-title":"Respir. Care."},{"issue":"6","key":"10.1016\/j.addr.2021.113901_b0845","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/17476348.2013.847369","article-title":"Aerosol therapy in children: challenges and solutions","volume":"7","author":"Ari","year":"2013","journal-title":"Expert Rev. Respir. Med."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b0850","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/ers.11.49","article-title":"Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy","volume":"5","author":"Ari","year":"2011","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.addr.2021.113901_b0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12030230","article-title":"In silico optimization of fiber-shaped aerosols in inhalation therapy for augmented targeting and deposition across the respiratory tract","volume":"12","author":"Shachar-berman","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.addr.2021.113901_b0860","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2147\/IJN.S29997","article-title":"Inhaled chemotherapy in lung cancer: Future concept of nanomedicine","volume":"7","author":"Zarogoulidis","year":"2012","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.addr.2021.113901_b0865","doi-asserted-by":"crossref","first-page":"110279","DOI":"10.1016\/j.jbiomech.2021.110279","article-title":"Focused targeting of inhaled magnetic aerosols in reconstructed in vitro airway models","volume":"118","author":"Ostrovski","year":"2021","journal-title":"J. Biomech."},{"issue":"6","key":"10.1016\/j.addr.2021.113901_b0870","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: Challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.addr.2021.113901_b0875","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2014.11.004","article-title":"Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead","volume":"85","author":"Velkov","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0880","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/10717544.2019.1676841","article-title":"Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates","volume":"26","author":"Poh","year":"2019","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0885","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/17425247.2020.1738380","article-title":"Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips","volume":"17","author":"Artzy-Schnirman","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0890","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cpt.742","article-title":"Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics","volume":"103","author":"Jain","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2021.113901_b0895","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nmeth.3697","article-title":"Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro","volume":"13","author":"Benam","year":"2016","journal-title":"Nat. Methods."},{"issue":"9643","key":"10.1016\/j.addr.2021.113901_b0900","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(08)61422-1","article-title":"Severe childhood asthma: a common international approach?","volume":"372","author":"Bush","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b0905","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1165\/rcmb.2020-0010MA","article-title":"A microengineered airway lung chip models key features of viral-induced exacerbation of asthma","volume":"63","author":"Nawroth","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0915","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/1061186X.2018.1455842","article-title":"Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need","volume":"27","author":"Patil","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2021.113901_b0920","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0925","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18231\/j.joapr.2019.v.8.i.1.003","article-title":"Liposome: a carrier for effective drug delivery","volume":"8","author":"Choudhury","year":"2020","journal-title":"J. Appl. Pharm. Res."},{"key":"10.1016\/j.addr.2021.113901_b0930","first-page":"711","article-title":"Liposomes: an overview of manufacturing techniques","volume":"10","author":"Mozafari","year":"2005","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.addr.2021.113901_b0935","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/nano6070125","article-title":"Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery","volume":"6","author":"Lombardo","year":"2016","journal-title":"Nanomaterials."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b0940","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/21691401.2014.953633","article-title":"Application of liposomes in medicine and drug delivery","volume":"44","author":"Daraee","year":"2016","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0945","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s13346-021-00929-2","article-title":"Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems","volume":"11","author":"Egorov","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.addr.2021.113901_b0950","doi-asserted-by":"crossref","unstructured":"O.R. Justo, \u00c2.M. Moraes, O.R. Justo, M. Moraes, Incorporation of Antibiotics in Liposomes Designed for Tuberculosis Therapy by Inhalation Incorporation of Antibiotics in Liposomes Designed \u0302, 7544 (2008). doi:10.1080\/713840401.","DOI":"10.1080\/713840401"},{"key":"10.1016\/j.addr.2021.113901_b0955","doi-asserted-by":"crossref","unstructured":"M. Rudokas, M. Najlah, M.A. Alhnan, A. Elhissi, Liposome Delivery Systems for Inhalation\u00a0: A Critical Review Highlighting Formulation Issues and Anticancer Applications, 25 (2016) 60\u201372. doi:10.1159\/000445116.","DOI":"10.1159\/000445116"},{"key":"10.1016\/j.addr.2021.113901_b0960","article-title":"Journal of Drug Delivery Science and Technology Recent advances in inhalable liposomes for treatment of pulmonary diseases : Concept to clinical stance","volume":"56","author":"Mehta","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1984","key":"10.1016\/j.addr.2021.113901_b0965","first-page":"76","article-title":"Cytotoxic T lymphocyte recognition of HLA-A\/B antigens introduced into EL4 cells by cell-liposome fusion","volume":"132","author":"Engelhard","year":"1950","journal-title":"J. Immunol. (Baltimore, Md."},{"issue":"13","key":"10.1016\/j.addr.2021.113901_b0970","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s40265-020-01359-z","article-title":"Inhaled Liposomal Antimicrobial Delivery in Lung Infections","volume":"80","author":"Bassetti","year":"2020","journal-title":"Drugs."},{"key":"10.1016\/j.addr.2021.113901_b0975","first-page":"33","article-title":"Liposomes as Advanced Delivery Systems for Nutraceuticals","volume":"15","author":"Shade","year":"2016","journal-title":"Integr. Med. A Clin. J."},{"issue":"3-4","key":"10.1016\/j.addr.2021.113901_b0980","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0264-410X(01)00326-7","article-title":"A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains","volume":"20","author":"Babai","year":"2001","journal-title":"Vaccine."},{"key":"10.1016\/j.addr.2021.113901_b0985","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.exppara.2012.09.001","article-title":"Experimental Parasitology The role of liposome size on the type of immune response induced in BALB \/ c mice against leishmaniasis : rgp63 as a model antigen","volume":"132","author":"Badiee","year":"2012","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0990","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0005-2736(00)00256-X","article-title":"Role of pulmonary surfactant components in surface film formation and dynamics","volume":"1467","author":"Veldhuizen","year":"2000","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b0995","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b1000","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20499-0","article-title":"Disulfide disruption reverses mucus dysfunction in allergic airway disease","volume":"12","author":"Morgan","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.addr.2021.113901_b1005","doi-asserted-by":"crossref","first-page":"2000013","DOI":"10.1002\/adtp.202000013","article-title":"Strategy to Enhance Dendritic Cell-Mediated DNA Vaccination in the Lung","volume":"3","author":"Kim","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.addr.2021.113901_b1010","unstructured":"About ARIKAYCE | ARIKAYCE (amikacin liposome inhalation suspension), (n.d.)."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b1015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","article-title":"Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease","volume":"79","author":"Shirley","year":"2019","journal-title":"Drugs."},{"key":"10.1016\/j.addr.2021.113901_b1020","first-page":"1","article-title":"Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2021.113901_b1025","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b1030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.23230","article-title":"Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to treating autoimmune arthritis","volume":"58","author":"Avnir","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2021.113901_b1035","doi-asserted-by":"crossref","unstructured":"F. L\u00fchder, Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids, (2017). doi:10.3390\/ijms18091836.","DOI":"10.3390\/ijms18091836"},{"key":"10.1016\/j.addr.2021.113901_b1040","doi-asserted-by":"crossref","unstructured":"M.A. Hegeman, P.M. Cobelens, J. Kamps, M.P. Hennus, dexamethasone attenuates ventilator-induced lung, (2011). doi:10.1111\/j.1476-5381.2011.01314.x.","DOI":"10.1111\/j.1476-5381.2011.01314.x"},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b1045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/08982104.2018.1531022","article-title":"Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy","volume":"29","author":"Honmane","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2021.113901_b1050","article-title":"Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery","volume":"7","author":"Chen","year":"2012","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.addr.2021.113901_b1055","doi-asserted-by":"crossref","unstructured":"D. Press, Onivyde for the therapy of multiple solid tumors, (2016) 3001\u20133007.","DOI":"10.2147\/OTT.S105587"},{"key":"10.1016\/j.addr.2021.113901_b1060","doi-asserted-by":"crossref","unstructured":"U. Bulbake, S. Doppalapudi, N. Kommineni, W. Khan, Liposomal Formulations in Clinical Use\u00a0: An Updated Review development, (2017) 1\u201333. doi:10.3390\/pharmaceutics9020012.","DOI":"10.3390\/pharmaceutics9020012"},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b1065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2009.06.017","article-title":"Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB\/IV) non-small cell lung cancer","volume":"68","author":"Mylonakis","year":"2010","journal-title":"Lung Cancer."},{"key":"10.1016\/j.addr.2021.113901_b1070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: Strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b1075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/10717544.2018.1425777","article-title":"Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide","volume":"25","author":"Lin","year":"2018","journal-title":"Drug Deliv."},{"issue":"8","key":"10.1016\/j.addr.2021.113901_b1080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41565-020-0751-0","article-title":"Nanotechnology-based disinfectants and sensors for SARS-CoV-2","volume":"15","author":"Talebian","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"2020","key":"10.1016\/j.addr.2021.113901_b1085","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"issue":"20","key":"10.1016\/j.addr.2021.113901_b1090","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 \u2014 Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.addr.2021.113901_b1095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ymthe.2019.02.019","article-title":"Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases","volume":"27","author":"Sahu","year":"2019","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.addr.2021.113901_b1100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2020.08.002","article-title":"Inhaled RNA Therapy: From Promise to Reality","volume":"41","author":"Chow","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b1105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2021.113901_b1110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8247935","article-title":"SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency","volume":"2018","author":"Connolly","year":"2018","journal-title":"J. Nucleic Acids."},{"issue":"1-2","key":"10.1016\/j.addr.2021.113901_b1115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/CritRevOncog.2016016084","article-title":"Gene therapy for lung cancer","volume":"21","author":"Lara-Guerra","year":"2016","journal-title":"Crit. Rev. Oncog."},{"issue":"8","key":"10.1016\/j.addr.2021.113901_b1120","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1208\/s12249-018-1183-0","article-title":"Nucleic Acid-Based Therapeutics for Pulmonary Diseases","volume":"19","author":"Chen","year":"2018","journal-title":"AAPS PharmSciTech."},{"issue":"24","key":"10.1016\/j.addr.2021.113901_b1125","doi-asserted-by":"crossref","first-page":"eaay7973","DOI":"10.1126\/sciadv.aay7973","article-title":"Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma","volume":"6","author":"da Silva","year":"2020","journal-title":"Sci. Adv."},{"issue":"28","key":"10.1016\/j.addr.2021.113901_b1130","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b1135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/mthe.2001.0435","article-title":"Challenges and strategies for cystic fibrosis lung gene therapy","volume":"4","author":"Koehler","year":"2001","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b1140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/genes10050387","article-title":"Gene and base editing as a therapeutic option for cystic fibrosis-learning from other diseases","volume":"10","author":"Mention","year":"2019","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.addr.2021.113901_b1145","article-title":"A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis","volume":"3","author":"Alton","year":"2016","journal-title":"Effic. Mech. Eval."},{"key":"10.1016\/j.addr.2021.113901_b1150","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2011.55","article-title":"Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung","volume":"18","author":"McLachlan","year":"2011","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.addr.2021.113901_b1155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: Current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.addr.2021.113901_b1160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2016.05.054","article-title":"Pulmonary administration of small interfering RNA: The route to go?","volume":"235","author":"Ruigrok","year":"2016","journal-title":"J. Control. Release."},{"issue":"15","key":"10.1016\/j.addr.2021.113901_b1165","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: First Global Approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs."},{"issue":"11","key":"10.1016\/j.addr.2021.113901_b1170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/gt.2017.83","article-title":"A new combination therapy for asthma using dual-function dexamethasone-conjugated polyethylenimine and Vitamin D binding protein siRNA","volume":"24","author":"Choi","year":"2017","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.addr.2021.113901_b1175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2020.04.007","article-title":"Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease","volume":"41","author":"Mei","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2021.113901_b1180","doi-asserted-by":"crossref","unstructured":"T.M. Calcagno, C. Zhang, R. Tian, B. Ebrahimi, M. Mirsaeidi, Novel three-dimensional biochip pulmonary sarcoidosis model., PLoS One. 16 (2021) e0245805. doi:10.1371\/journal.pone.0245805.","DOI":"10.1371\/journal.pone.0245805"},{"issue":"2","key":"10.1016\/j.addr.2021.113901_b1185","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/bit.27600","article-title":"Development of a dynamic in vitro stretch model of the alveolar interface with aerosol delivery","volume":"118","author":"Cei","year":"2021","journal-title":"Biotechnol. Bioeng."},{"issue":"10","key":"10.1016\/j.addr.2021.113901_b1190","doi-asserted-by":"crossref","first-page":"2004707","DOI":"10.1002\/adfm.202004707","article-title":"Copolymeric Membrane for Cell-Stretch Experiments with Pulmonary Epithelial Cells at the Air-Liquid Interface","volume":"31","author":"Doryab","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b1195","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1021\/la903038a","article-title":"Dynamics of Liquid Plugs of Buffer and Surfactant Solutions in a Micro-Engineered Pulmonary Airway Model","volume":"26","author":"Tavana","year":"2010","journal-title":"Langmuir"},{"issue":"17","key":"10.1016\/j.addr.2021.113901_b1200","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1039\/C4LC00552J","article-title":"A biomimetic multicellular model of the airways using primary human cells","volume":"14","author":"Sellgren","year":"2014","journal-title":"Lab Chip."},{"issue":"5","key":"10.1016\/j.addr.2021.113901_b1205","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cels.2016.10.003","article-title":"Matched-Comparative Modeling of Normal and Diseased Human Airway Responses Using a Microengineered Breathing Lung Chip","volume":"3","author":"Benam","year":"2016","journal-title":"Cell Syst."},{"key":"#cr-split#-10.1016\/j.addr.2021.113901_b1210.1","doi-asserted-by":"crossref","unstructured":"B.A. Hassell, G. Goyal, E. Lee, A. Sontheimer-Phelps, O. Levy, C.S. Chen, D.E. Ingber, Erratum: Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro (Cell Reports (2017) 21","DOI":"10.1016\/j.celrep.2017.09.043"},{"key":"#cr-split#-10.1016\/j.addr.2021.113901_b1210.2","doi-asserted-by":"crossref","unstructured":"(2) (508-516) (S2211124717313311) (10.1016\/j.celrep.2017.09.043)), Cell Rep. (2017) 508-516. doi:10.1016\/j.celrep.2018.06.028.","DOI":"10.1016\/j.celrep.2018.06.028"},{"key":"10.1016\/j.addr.2021.113901_b1215","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1039\/C4IB00149D","article-title":"The potential of microfluidic lung epithelial wounding: towards in vivo-like alveolar microinjuries","volume":"6","author":"Felder","year":"2014","journal-title":"Integr. Biol."},{"key":"10.1016\/j.addr.2021.113901_b1220","doi-asserted-by":"crossref","DOI":"10.1039\/C7LC01224A","article-title":"Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing","author":"Yang","year":"2018","journal-title":"Lab Chip."},{"key":"10.1016\/j.addr.2021.113901_b1225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01985-4","article-title":"Microbial volatile communication in human organotypic lung models","author":"Barkal","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.113901_b1230","doi-asserted-by":"crossref","DOI":"10.1039\/C8TX00156A","article-title":"A 3D human lung-on-a-chip model for nanotoxicity testing","author":"Zhang","year":"2018","journal-title":"Toxicol. Res. (Camb)."},{"key":"10.1016\/j.addr.2021.113901_b1235","doi-asserted-by":"crossref","unstructured":"G.A.H. Remi Villenave , Carolina Lucchesi , Deion Cheng , Hyun Hee Lee , Justin Nguyen , Antonio Varone , Katia Karalis , Stephen Alves , Michael Salmon, Severe asthma-on-chip: A novel in vitro platform to model viral-induced exacerbations in asthma, Am. J. Respir. Crit. Care Med. 95 (2017) A4961.","DOI":"10.1183\/1393003.congress-2017.PA4136"},{"key":"10.1016\/j.addr.2021.113901_b1240","first-page":"1","article-title":"Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex : a therapeutic strategy for cystic fibrosis","author":"Manunta","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.113901_b1245","doi-asserted-by":"crossref","unstructured":"K. Ahmad, G.C. Alex, H. Zem, G. Now, M.E. Eybye, X. Zhu, E. Guadagnin, R.A. White, L.M. Rice, L.F. Andrea, S. St, C. Jo, G.V.M. Paolo, E. Ewa, Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency, (2020) 1\u201311. doi:10.1038\/s41598-020-64017-0.","DOI":"10.1038\/s41598-020-64017-0"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:05:52Z","timestamp":1759208752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":249,"alternative-id":["S0169409X21002945"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.113901","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.113901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113901"}}